Last reviewed · How we verify

NCT03387644

Pregabalin Premedication for Conscious Sedation

Completed NA Last updated 2 January 2018
What this trial tests

NA trial testing Pregabalin (PG) in Conscious Sedation in 70 participants. Completed in 16 May 2017.

Timeline
15 April 2015
Primary endpoint
24 November 2016
16 May 2017

Quick facts

Lead sponsorMenoufia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposeother
Enrollment70
Start date15 April 2015
Primary completion24 November 2016
Estimated completion16 May 2017

Drugs / interventions tested

Conditions studied

Sponsor

Menoufia University

Who can join

Adults 21 to 65, any sex, with Conscious Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Conscious sedation is usually required during flexible bronchoscopy. Sedation should be done without causing respiratory depression or loss of consciousness. The present study was designed to evaluate the advantage of pregabalin pre-medication on reducing sedatives and respiratory depression for patients undergoing flexible bronchoscopy with dexmedetomidine and midazolam.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Conscious Sedation

Currently open trials in the same condition.

Other Menoufia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03387644.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing